This is a national requirements contract to supply Repaglinide Tablets (0.5MG, 1MG, and 2MG in 100-count bottles) for the Department of Defense exclusively through the DLA prime vendor program. The contract will be firm-fixed price with a one-year base period and four one-year option periods. The performance of services is national in scope to establish a supply source for DOD purchase. The solicitation is unrestricted and fully competitive, open to all sources for proposal submission. The annual usage estimates will be detailed in the solicitation's Schedule of Supplies.